progressive renal failure. End stage renal disease
Conditions
Interventions
Intervention 1: Operation to create hemodialysis access for arteriovenous graft including exploration of brachial artery and axillary vein and pass the graft 6 mm from subcutaneous area of arm and the
Treatment - Surgery
Operation to create hemodialysis access for arteriovenous graft including exploration of brachial artery and axillary vein and pass the graft 6 mm from subcutaneous area of arm and then vascular anast
Operation to create hemodialysis access for arteriovenous graft including exploration of brachial artery and axillary vein and pass the graft(4-7mm) from subcutaneous area of arm and then vascular ana
Sponsors
Mazandaran University of Medical Sciences vice chancellor of research
Eligibility
Sex/Gender
All
Age
30 Years to 100 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:no history of previous AVG;do not use anticoagulant drugs exclusion criteria:previous AVG;using anticoagulant drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary patency time. Timepoint: 2weeks, 1month, 2months, 3months, 6months, after every 3months to years after surgerys. Method of measurement: doppler sonography, examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms of thrombosis(pain,redness,swelling). Timepoint: 2weeks,1month,2months,3months,6months,after every 3months to2 years after surgery. Method of measurement: examination,observation.;Thrill in embedded pathway. Timepoint: 2weeks,1month,2months,3months,6months,after every 3months to2 years after surgery. Method of measurement: examination,observation.;Symptoms of infection(pain,redness,swelling). Timepoint: 2weeks,1month,2months,3months,6months,after every 3months to2 years after surgery. Method of measurement: examination,observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Azadeh Beheshtian
Mazandaran University of Medical Sciences
Outcome results
None listed